Paul Hartmann AG (PHH2) - Total Liabilities

Latest as of December 2025: €938.79 Million EUR ≈ $1.10 Billion USD

Based on the latest financial reports, Paul Hartmann AG (PHH2) has total liabilities worth €938.79 Million EUR (≈ $1.10 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Paul Hartmann AG - Total Liabilities Trend (2013–2025)

This chart illustrates how Paul Hartmann AG's total liabilities have evolved over time, based on quarterly financial data. See Paul Hartmann AG (PHH2) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Paul Hartmann AG Competitors by Total Liabilities

The table below lists competitors of Paul Hartmann AG ranked by their total liabilities.

Company Country Total Liabilities
Geron Corporation
NASDAQ:GERN
USA $305.01 Million
Anhui Ronds Science & Technology Inc Co
SHG:688768
China CN¥328.64 Million
Shanghai Xinhua Media Co Ltd
SHG:600825
China CN¥1.42 Billion
Minerva S.A
SA:BEEF3
Brazil R$39.79 Billion
Hua Yuan Property Co Ltd
SHG:600743
China CN¥1.06 Billion
Sijin Intelligent Forming Machinery
SHE:003025
China CN¥296.09 Million
Chengdu XGimi Technology Co. Ltd. A
SHG:688696
China CN¥2.62 Billion
Fujian SuperTech Advanced Material Co Ltd
SHG:688398
China CN¥945.69 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Paul Hartmann AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Paul Hartmann AG worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.22 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.80 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.43 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Paul Hartmann AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Paul Hartmann AG (2013–2025)

The table below shows the annual total liabilities of Paul Hartmann AG from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 €938.79 Million
≈ $1.10 Billion
+4.10%
2024-12-31 €901.80 Million
≈ $1.05 Billion
+3.51%
2023-12-31 €871.24 Million
≈ $1.02 Billion
-0.75%
2022-12-31 €877.81 Million
≈ $1.03 Billion
+19.91%
2021-12-31 €732.05 Million
≈ $855.85 Million
-3.32%
2020-12-31 €757.19 Million
≈ $885.23 Million
+11.85%
2019-12-31 €676.95 Million
≈ $791.43 Million
+17.49%
2018-12-31 €576.16 Million
≈ $673.59 Million
-0.17%
2017-12-31 €577.13 Million
≈ $674.73 Million
+12.47%
2016-12-31 €513.13 Million
≈ $599.90 Million
-1.23%
2015-12-31 €519.52 Million
≈ $607.37 Million
-6.70%
2014-12-31 €556.83 Million
≈ $650.99 Million
+3.17%
2013-12-31 €539.74 Million
≈ $631.01 Million
--

About Paul Hartmann AG

F:PHH2 Germany Medical Instruments & Supplies
Market Cap
$863.69 Million
€738.76 Million EUR
Market Cap Rank
#10601 Global
#1232 in Germany
Share Price
€208.00
Change (1 day)
+0.00%
52-Week Range
€201.00 - €249.00
All Time High
€376.24
About

Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Wound Care, Incontinence Management, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management p… Read more